Relaxation of rabbit cavernous smooth muscle to 17beta-estradiol: a non-genomic, NO-independent mechanism

Asian J Androl. 2004 Jun;6(2):127-31.

Abstract

Aim: To investigate whether estrogen was involved in relaxation of rabbit cavernous smooth muscle.

Methods: Relaxation response of the rabbit cavernous smooth muscles to 17beta-estradiol (0.3, 3, 30 and 300 nmol/L) were observed in vitro. The response of the muscle strips to estrogen after incubation with either actinomycin D (10 micromol/L) or L-NAME (10 micromol/L) were also evaluated. Inside-out mode of patch clamp in a single smooth muscle cell was applied to investigate the Maxi-K channel activities.

Results: Estrogen caused a dose-dependent relaxation of the strips precontracted with norepinephrine. The maximal response was noted about 10 minutes after treatment. The estrogen-induced relaxation was prevented by neither actinomycin D nor L-NAME, suggesting that the response was not mediated by gene transcription or nitric oxide (NO). Application of 17beta-estradiol increased the Maxi-K channel activities.

Conclusion: 17beta-estradiol may be involved in relaxation of rabbit cavernous smooth muscles via a non-genomic and NO independent mechanism. 17beta-estradiol stimulates Maxi-K channel of the rabbit cavernous myocyte.

MeSH terms

  • Animals
  • Dactinomycin / pharmacology
  • Dose-Response Relationship, Drug
  • Electrophysiology
  • Enzyme Inhibitors / pharmacology
  • Estradiol / pharmacology*
  • In Vitro Techniques
  • Indicators and Reagents
  • Male
  • Membrane Potentials / drug effects
  • Muscle Relaxation / drug effects
  • Muscle, Smooth / drug effects*
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Nitric Oxide Synthase Type III
  • Norepinephrine / pharmacology
  • Patch-Clamp Techniques
  • Penis / drug effects*
  • Peptides / pharmacology
  • Potassium Channel Blockers / pharmacology
  • Rabbits
  • Vasoconstrictor Agents / pharmacology

Substances

  • Enzyme Inhibitors
  • Indicators and Reagents
  • Peptides
  • Potassium Channel Blockers
  • Vasoconstrictor Agents
  • Dactinomycin
  • Estradiol
  • iberiotoxin
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type III
  • NG-Nitroarginine Methyl Ester
  • Norepinephrine